Clinical Trials Directory

Trials / Completed

CompletedNCT05501613

Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)

Early Multimodal Neuromonitoring Parameters as Prognostic Factors For Critically Ill Spontaneous ICH Patients

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Universidade do Porto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.

Detailed description

Retrospective observational study based on analyzing the first 48 hours of the multimodal neuromonitoring signal, from spontaneous ICH patients, whose treatment includes invasive intraparenchymal neuromonitoring, treated from January 2015 to September 2021 in a tertiary hospital.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMultimodal NeuromonitoringInvasive Multimodal Neuromonitoring

Timeline

Start date
2015-01-01
Primary completion
2022-10-01
Completion
2023-02-01
First posted
2022-08-15
Last updated
2023-02-06

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT05501613. Inclusion in this directory is not an endorsement.